New targeted immunotherapy – pulmonary metastases

Immunomodulating therapy – reshapes the tumour microenvironment

Shifts towards a proinflammatory tumour microenvironment – allowing the adaptive immune system to mount an anti-tumour response

Localized effect – less systemic side effects and higher local concentration

Repurposed drug – knowledge about safety and shorter path to clinics

Short delivery time – patients are in and out of the hospital quickly

Does not require expensive machinery – can be performed in any hospital